Paper17606256
Combined metadoxine and garlic oil treatment efficaciously abrogates alcoholic steatosis and CYP2E1 induction in rat liver with restoration of AMPK activity.
Ki SH and 3 others. Chem Biol Interact, 2007. Cited by 40 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Combined metadoxine and garlic oil treatment efficaciously abrogates alcoholic steatosis and CYP2E1 induction in rat liver with restoration of AMPK activity. Papers, record 17606256. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17606256
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Combined metadoxine and garlic oil treatment efficaciously abrogates alcoholic steatosis and CYP2E1 induction in rat liver with restoration of AMPK activity.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenylate Kinase | Major topic |
| Alcoholism | Major topic |
| Allyl Compounds | Major topic |
| Cytochrome P-450 CYP2E1 | Major topic |
| Fatty Liver | Major topic |
| Liver | Major topic |
| Pyridoxine | Major topic |
| Pyrrolidonecarboxylic Acid | Major topic |
| Sulfides | Major topic |
| Animals | |
| Drug Combinations | |
| Enzyme Induction | |
| Rats | |
| Rats, Sprague-Dawley | |
| Triglycerides |
Source PubMed
Cited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 40 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40699438 | Exploring the role of xanthine oxidase and aldehyde oxidase in metabolic dysfunction-associated steatotic liver disease (MASLD). | J Mol Histol | 2025 | https://conductscience.org/library/papers/40699438 | PubMed |
| 38813108 | Transcriptomic analysis reveals pharmacological mechanisms mediating efficacy of Yangyinghuoxue Decoction in CCl4-induced hepatic fibrosis in rats. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/38813108 | PubMed |
| 36721803 | Toll-Like Receptor 4 (TLR4) and AMPK Relevance in Cardiovascular Disease. | Adv Pharm Bull | 2023 | https://conductscience.org/library/papers/36721803 | PubMed |
| 34558087 | A review of the role of ethanol-induced adipose tissue dysfunction in alcohol-associated liver disease. | Alcohol Clin Exp Res | 2021 | https://conductscience.org/library/papers/34558087 | PubMed |
| 29862216 | Hepatoprotective Effect of Metadoxine on Acetaminophen-induced Liver Toxicity in Mice. | Adv Biomed Res | 2018 | https://conductscience.org/library/papers/29862216 | PubMed |
| 28093021 | Altering ethanol pharmacokinetics to treat alcohol use disorder: Can you teach an old dog new tricks? | J Psychopharmacol | 2017 | https://conductscience.org/library/papers/28093021 | PubMed |
| 28074114 | Low-ω3 Fatty Acid and Soy Protein Attenuate Alcohol-Induced Fatty Liver and Injury by Regulating the Opposing Lipid Oxidation and Lipogenic Signaling Pathways. | Oxid Med Cell Longev | 2016 | https://conductscience.org/library/papers/28074114 | PubMed |
| 26764240 | Targeting AMPK signaling in combating ovarian cancers: opportunities and challenges. | Acta Biochim Biophys Sin (Shanghai) | 2016 | https://conductscience.org/library/papers/26764240 | PubMed |
| 26585415 | Defect of mitochondrial respiratory chain is a mechanism of ROS overproduction in a rat model of alcoholic liver disease: role of zinc deficiency. | Am J Physiol Gastrointest Liver Physiol | 2016 | https://conductscience.org/library/papers/26585415 | PubMed |
| 26264202 | Diallyl Sulfide: Potential Use in Novel Therapeutic Interventions in Alcohol, Drugs, and Disease Mediated Cellular Toxicity by Targeting Cytochrome P450 2E1. | Curr Drug Metab | 2015 | https://conductscience.org/library/papers/26264202 | PubMed |
| 26045683 | Korean Red Ginseng attenuates ethanol-induced steatosis and oxidative stress via AMPK/Sirt1 activation. | J Ginseng Res | 2015 | https://conductscience.org/library/papers/26045683 | PubMed |
| 24892905 | CMZ reversed chronic ethanol-induced disturbance of PPAR-α possibly by suppressing oxidative stress and PGC-1α acetylation, and activating the MAPK and GSK3β pathway. | PLoS One | 2014 | https://conductscience.org/library/papers/24892905 | PubMed |
| 23102217 | AMP-activated protein kinase: a target for drugs both ancient and modern. | Chem Biol | 2012 | https://conductscience.org/library/papers/23102217 | PubMed |
| 22564350 | Ascorbic acid supplementation causes faster restoration of reduced glutathione content in the regression of alcohol-induced hepatotoxicity in male guinea pigs. | Redox Rep | 2012 | https://conductscience.org/library/papers/22564350 | PubMed |
| 21553301 | Biochemical and histological liver changes occurred after iron supplementation and possible remediation by garlic consumption. | Endocrine | 2011 | https://conductscience.org/library/papers/21553301 | PubMed |
| 20698033 | AMPK-associated signaling to bridge the gap between fuel metabolism and hepatocyte viability. | World J Gastroenterol | 2010 | https://conductscience.org/library/papers/20698033 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17606256
GET https://conductscience.org/api/papers/v1/17606256/authors